Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial
Maura L. Gillison, Andy Trotti, Jonathan Harris, Avraham Eisbruch, Paul M. Harari, David J. Adelstein, Richard C. Jordan, Weiqiang Zhao, Erich M. Sturgis, Barbara Burtness, John A. Ridge, Jolie Ringash, James M. Galvin, Min Yao, Shlomo A. Koyfman, Dukagjin Blakaj, Mohammed A. Razaq, A. Dimitrios Colevas, Jonathan J. Beitler, Christopher U. Jones, Neal Dunlap, Samantha A. Seaward, Sharon A. Spencer, Thomas J. Galloway, Jack Phan, James J. Dignam, Quynh‐Thu Le
Topics & Concepts
CetuximabMedicineRadiation therapyInternal medicineOncologyCisplatinCancerChemotherapyColorectal cancerHead and Neck Cancer StudiesEsophageal Cancer Research and TreatmentColorectal and Anal Carcinomas